Medically reviewed by Drugs.com. Last updated on Sep 21, 2020.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
(50% Urea) In a lactic acid & salicylic acid vehicle
For external use only.
Not for ophthalmic use.
The Latrix brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Each gram of Latrix™ Topical Suspension contains: ACTIVE: 50% Urea in a topical suspension base of INACTIVES: consisting of Caprylic/Capric Triglyceride, Carbomer, Cetyl Alcohol, Edetate Disodium, Glycerin, Hydroxyethylcellulose, Lactic Acid, Linoleic Acid, PEG-6, Polysorbate 60, Propylene Glycol, Purified Water, Salicylic Acid, Sorbitan Stearate, Titanium Dioxide, Trolamine, Vitamin E and Xanthan Gum.
Urea is a diamide of carbonic acid with the following chemical structure:
Latrix - Clinical Pharmacology
Urea gently dissolves the intercellular matrix, which results in loosening the homy layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas.
The mechanism of action of topically applied Urea is not yet known.
INDICATIONS AND USES
For debridement and promotion of normal healing of hyperkeratolic surface lesions, particularly where healing is retarded by local infection, necrotic tissues, fibrinour or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis Palmaris, keratoderma, corns and calluses.
Known hypersensitivity to any of the listed ingredients.
For external use only. Avoid contact with eyes, lips or mucous membranes.
This medication is to be used as directed by a physician and should not be used to treat any condition other then that for which it was prescribed. If redness or irritation occurs, discontinue use.
PREGNANCYPregnancy Category B
Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Latrix™ Topical Suspension should be given to a pregnant woman only if clearly needed.
It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Latrix™ Topical Suspension is administered to a nursing woman.
Keep this and all other medications out of reach of children.
Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.
Latrix Dosage and Administration
Apply Latrix™ Topical Suspension to the affected skin twice per day, or as directed by a physician. Rub in until completely absorbed.
How is Latrix Supplied
Latrix™ Topical Suspension (50% Urea) is supplied as:
- 284g (10oz) tube, NDC 58980-777-10
Store at controlled room temperature 15°-30° C (59°-86° F.) Protect from freezing.
STRATUS PHARMACEUTICALS INC
14377 SW 142ND Street, Miami, Florida 33186
PRINCIPAL DISPLAY PANEL - 284 g Carton
In a lactic acid &
salicylic acid vehicle
For Topical Use Only
Net Wt. 10 oz (284 g)
|Labeler - Stratus Pharmaceuticals, Inc (789001641)|
|Registrant - Sonar Products, Inc (104283945)|
|Sonar Products, Inc||104283945||MANUFACTURE|